Biomerica, Inc. (NASDAQ:BMRA) Sees Significant Growth in Short Interest

Biomerica, Inc. (NASDAQ:BMRA) saw a large growth in short interest in the month of February. As of February 15th, there was short interest totalling 419,000 shares, a growth of 64.6% from the January 31st total of 254,500 shares. Based on an average trading volume of 7,750,000 shares, the short-interest ratio is presently 0.1 days.

Biomerica Price Performance

Shares of Biomerica stock traded down $0.05 during trading on Tuesday, hitting $0.67. 255,747 shares of the company’s stock traded hands, compared to its average volume of 2,201,124. The company has a market cap of $12.19 million, a PE ratio of -1.96 and a beta of -0.98. The firm’s fifty day moving average price is $0.56 and its 200 day moving average price is $0.42. Biomerica has a twelve month low of $0.24 and a twelve month high of $1.27.

Biomerica (NASDAQ:BMRA) last released its quarterly earnings data on Tuesday, January 14th. The company reported ($0.06) earnings per share for the quarter. Biomerica had a negative net margin of 100.52% and a negative return on equity of 90.19%.

Institutional Trading of Biomerica

An institutional investor recently raised its position in Biomerica stock. Granahan Investment Management LLC raised its stake in shares of Biomerica, Inc. (NASDAQ:BMRA) by 24.9% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 658,767 shares of the company’s stock after acquiring an additional 131,306 shares during the quarter. Granahan Investment Management LLC owned approximately 3.59% of Biomerica worth $198,000 as of its most recent filing with the SEC. Institutional investors own 22.28% of the company’s stock.

About Biomerica

Biomerica, Inc, a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications; or to measure bacteria, hormones, antibodies, antigens, or other substances which may exist in the human body, stools, or blood in extremely small concentrations.